Phase Forward to Present at the Thomas Weisel Partners Technology and Telecom Conference 2009

WALTHAM, Mass.--(Business Wire)--
Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management
solutions for clinical trials and drug safety, today announced its chief
executive officer and president, Bob Weiler, and chief financial officer, Rodger
Weismann, will present at the Thomas Weisel Partners Technology and Telecom
Conference 2009 at the Fairmont Hotel in San Francisco.

The Phase Forward presentation is scheduled for Wednesday, February 11, 2009 at
1:30 p.m. PT. The presentation will be webcast live and will be available by
visiting the Investors section of the company`s website at www.phaseforward.com.
The webcast will be archived on the company`s website for 30 days after the
conference ends.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for
clinical trials and drug safety. The company offers proven solutions for
electronic data capture (InForm(TM)), phase I clinic automation (LabPas(TM)),
clinical data management (Clintrial(TM)), clinical trials signal detection
(CTSD(TM)), strategic pharmacovigilance (Empirica Signal(TM)) and Signal
Management, adverse event reporting (Empirica Trace(TM)), applied data standards
(WebSDM(TM)) and Web-integrated interactive response technologies (Clarix(TM)).
In addition, the company provides services in the areas of application
implementation, hosting and validation, data integration, business process
optimization, safety data management and industry standards. Phase Forward's
products and services have been utilized in over 10,000 clinical trials
involving more than 1,000,000 clinical trial study participants at over 280
organizations and regulatory agencies worldwide including: AstraZeneca, Boston
Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug
Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck
Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble,
Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec
and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional
information about Phase Forward is available at www.phaseforward.com.

Public Relations
CHEN PR, Inc.
Barbara Heffner, 781-672-3112
bheffner@chenpr.com
or
Investor Relations
Integrated Corporate Relations
Timothy Dolan, 617-956-6727
tdolan@icrinc.com

Copyright Business Wire 2009